Daily Markup #39: Startup inks $4M deal to get Premier League players back to the pitch

Football season is coming back, slowly but surely.

Healthtech and football

  • Last month, 500-backed genetics testing and digital health company Prenetics launched Project Screen in Hong Kong to ramp up efforts for Covid-19 testing.
  • Using the latest digital and ISO-laboratory standards, users can receive, return, and access results within 24 hours.
Credit: Danny Yeung Instagram
  • Now, the UK Premier League has tapped Prenetics to get players and staff back to the pitch. The partnership has been confirmed by CEO and founder Danny Yeung.
Photo by Thomas Serer on Unsplash
  • In an interview on NOW TV, Danny talks more about Project Screen and why stringent testing is important when kickstarting any major sporting events post-Covid-19.

https://www.linkedin.com/posts/prenetics_prenetics-premierleague-projectscreen-activity-6670594628804218880-FEmk

Education fair goes virtual

  • Physical mass gatherings aren’t exactly a good idea these days. So, 500-backed EduAdvisor is migrating its education fair to the digital sphere.
  • Held next week, 1-June, the EduAdvisor Virtual Education Fair will take place from the comfort of your own homes. Explore universities, scholarships, and courses from esteemed Malaysia-based learning institutions like the University of Malaya (UM), Newcastle University, and Heriot Wart University.
Credit: EduAdvisor
  • At the “fair”, there’ll be live counseling sessions and on-the-spot career tests at booths that mimic their real-life counterparts. Only this time, you can skip the crowd and the parking woes.
  • Get more details in the link and share it if you know someone who will benefit from this!

The rest is history

  • 60 days. That was the time frame given to Faruok Marelli to secure his first client for mClinica.
  • With no tech, no team, and having to do it in the Philippines, a country he had not visited before. Farouk called it “the scariest 60 days of his life” in an interview with TechNode where he revisited the early, grueling days of entrepreneurship.
Credit: e27
  • But he made it work. 500-backed mClinica now connects over 40,000 pharmacies in Southeast Asia. Big pharma giants like Pfizer and Novartis count as clients too.
  • Besides that, it continues to work with leading healthcare organizations including the Ministries of Health in Indonesia, Cambodia, and the Philippines as well as renowned academic institutions like John Hopkins and USAID.
  • Amidst the coronavirus crisis, Farouk and his team are certainly busier than ever. Stay up to date with mClinica here.

Missed out the last few Durian Daily editions? Go here for a full recap.

You can also find us on LinkedIn, Facebook, Twitter, and Instagram.

500 Startups is a venture capital firm on a mission to discover and back the world’s most talented entrepreneurs, help them create successful companies at scale, and build thriving global ecosystems. In Southeast Asia, 500 Startups invests through the pioneering 500 Southeast Asia family of funds. The 500 Southeast Asia funds have backed over 240 companies across multiple sectors from internet to consumer to deep technology. It continues to connect founders with capital, expertise and powerful regional and global networks to help them succeed.


This post is intended solely for general informational or educational purposes only. 500 Startups Management Company, L.L.C. and its affiliates (collectively “500 Startups”) makes no representation as to the accuracy or information in this post and while reasonable steps have been taken to ensure that the information herein is accurate and up-to-date, no liability can be accepted for any error or omissions. All third party links in this post have not been independently verified by 500 Startups and the inclusion of such links should not be interpreted as an endorsement or confirmation of the content within. Under no circumstances should any content in this post be construed as investment, legal, tax or accounting advice by 500 Startups, or an offer to sell or solicitation of interest to purchase any securities advised by 500 Startups. Prospective investors considering an investment into any 500 Startups fund should not consider or construe this content as fund marketing material. The views expressed herein are as at the date of this post and are subject to change without notice. A 500 Startups fund may have a financial interest in one or more of the companies discussed.

0

Share

Daily Markup